Skip to content
AnalystLens

CACI International 8-K Report, Executive Changes (Jun 22, 2026)

Reports
Leadership Changes·Exhibits & Filings
Filing Date
Filed June 22, 2026
Period End
June 22, 2026
Security
CACI
In the record · 2016–202610-K1110-Q338-K122

CACI filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 122 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Feb ’16Feb ’16
  2. Leadership change8-K · Jun ’19Jun ’19
  3. Leadership change8-K · Aug ’21Aug ’21
  4. Material agreement8-K · Jun ’25Jun ’25

Summary

Summary of the 8-K filed June 22, 2026. Cited figures are marked; the original filing is the authoritative source.

CACI International Inc (NYSE: CACI) filed a Current Report on Form 8-K dated June 22, 2026, announcing the appointment of Dr. David (Dave) Young as Executive Vice President and Chief Operating Officer.

He reports to John Mengucci, CACI President and Chief Executive Officer, and will serve on the company's executive leadership team. The filing describes him as having 25 years of experience, most recently as Vice President and General Manager of National Security Space at Lockheed Martin from December 2024 to June 2026, and previously as Chief Operating Officer of CAES from January 2021 to September 2024. Under the filing's compensation terms, Dr. Young will participate in the company's annual bonus plan and long-term incentive program, customary for his position.

He will also receive a one-time cash sign-on bonus of $500,000a and a grant of $2,000,000 in restricted stock units vesting in three equal annual installments beginning on the first anniversary of his employment. The filing states there is no arrangement under which he was selected, no family relationships with directors or executive officers, and no related party transactions under Item 404(a) of Regulation S-K.

The press release (Exhibit 99.1) describes Young's prior role as overseeing a business with approximately $7 billionb in revenue at Lockheed Martin, covering more than 250 defense and intelligence community programs and a team of more than 10,000 employees. Management characterized the hire as supporting the company's growth and execution for national security customers.

Key Highlights

  1. Dr. David Young appointed Executive Vice President and Chief Operating Officer, reporting to CEO John Mengucci
  2. Young previously served as Vice President and General Manager of National Security Space at Lockheed Martin (December 2024 to June 2026), a business with approximately $7 billion in revenue
  3. Prior to Lockheed Martin, Young was Chief Operating Officer of CAES from January 2021 to September 2024
  4. Sign-on compensation includes a one-time $500,000 cash bonus and a $2,000,000 restricted stock unit grant vesting in three equal annual installments
  5. Young will also participate in the company's annual bonus plan and long-term incentive program
  6. Filing states no family relationships, no related party transactions, and no arrangement under which he was selected as an officer
  7. The 8-K includes the press release as Exhibit 99.1 and the Inline XBRL cover page as Exhibit 104

Frequently Asked Questions

  1. Who is the new Chief Operating Officer of CACI?

    Dr. David (Dave) Young, age 45, has been appointed Chief Operating Officer and serves as Executive Vice President. He reports to CEO John Mengucci and will serve on the executive leadership team.

  2. What is Dr. Young's relevant background?

    The filing states he has 25 years of experience. He was Vice President and General Manager of National Security Space at Lockheed Martin from December 2024 to June 2026, Vice President and Deputy General Manager of the same unit from September to December 2024, and Chief Operating Officer of CAES from January 2021 to September 2024. He previously held roles at Lockheed Martin and spent 11 years at Northrop Grumman.

  3. What compensation will Dr. Young receive?

    He will participate in the annual bonus plan and long-term incentive program customary for his position. He will also receive a one-time cash sign-on bonus of $500,000 and a grant of $2,000,000 in restricted stock units that vest in three equal annual installments beginning on the first anniversary of his employment.

  4. Are there any related-party or family relationships tied to the appointment?

    The filing states there are no family relationships between Dr. Young and any director or executive officer, and no related party transactions of the kind described in Item 404(a) of Regulation S-K in which he was a participant.

  5. What did the company say about the appointment?

    In the press release, CEO John Mengucci said Young's operational discipline, strategic perspective, and leadership experience will strengthen how CACI executes, supports growth, and pursues the opportunities ahead.